Tammy Utset to Male
This is a "connection" page, showing publications Tammy Utset has written about Male.
Connection Strength
0.263
-
Significance of chronic tachycardia in systemic lupus erythematosus. Arthritis Care Res (Hoboken). 2013 May; 65(5):827-31.
Score: 0.024
-
Correlates of sleep abnormalities in systemic lupus: a cross-sectional survey in an urban, academic center. J Clin Rheumatol. 2013 Jan; 19(1):7-13.
Score: 0.023
-
A study of racial/ethnic differences in treatment preferences among lupus patients. Rheumatology (Oxford). 2012 Sep; 51(9):1697-706.
Score: 0.022
-
Correlates of formal work disability in an urban university systemic lupus erythematosus practice. J Rheumatol. 2008 Jun; 35(6):1046-52.
Score: 0.017
-
Whole blood viscosity and arterial thrombotic events in patients with systemic lupus erythematosus. Arthritis Rheum. 2007 Jun 15; 57(5):845-50.
Score: 0.016
-
Prevalence of neurocognitive dysfunction and other clinical manifestations in disabled patients with systemic lupus erythematosus. J Rheumatol. 2006 Mar; 33(3):531-8.
Score: 0.014
-
Neuropsychologic functioning and health status in systemic lupus erythematosus: does ethnicity matter? J Clin Rheumatol. 2005 Oct; 11(5):250-6.
Score: 0.014
-
Mycophenolate mofetil withdrawal in patients with systemic lupus erythematosus: a multicentre, open-label, randomised controlled trial. Lancet Rheumatol. 2024 Mar; 6(3):e168-e177.
Score: 0.012
-
Can disease specific measures for systemic lupus erythematosus predict patients health related quality of life? Lupus. 2004; 13(12):924-6.
Score: 0.012
-
Modified anti-CD3 therapy in psoriatic arthritis: a phase I/II clinical trial. J Rheumatol. 2002 Sep; 29(9):1907-13.
Score: 0.011
-
Unique Sjögren's syndrome patient subsets defined by molecular features. Rheumatology (Oxford). 2020 04 01; 59(4):860-868.
Score: 0.010
-
Genetic fine mapping of systemic lupus erythematosus MHC associations in Europeans and African Americans. Hum Mol Genet. 2018 11 01; 27(21):3813-3824.
Score: 0.009
-
Clinical Efficacy and Safety of Baminercept, a Lymphotoxin ß Receptor Fusion Protein, in Primary Sjögren's Syndrome: Results From a Phase II Randomized, Double-Blind, Placebo-Controlled Trial. Arthritis Rheumatol. 2018 09; 70(9):1470-1480.
Score: 0.008
-
Retinal nerve fiber layer and macular thinning in systemic lupus erythematosus: an optical coherence tomography study comparing SLE and neuropsychiatric SLE. Lupus. 2015 Oct; 24(11):1169-76.
Score: 0.007
-
Depressive symptoms in patients with systemic lupus erythematosus: association with central nervous system lupus and Sjögren's syndrome. J Rheumatol. 1994 Nov; 21(11):2039-45.
Score: 0.007
-
Racial differences in treatment preferences among lupus patients: a two-site study. Clin Exp Rheumatol. 2014 Sep-Oct; 32(5):680-8.
Score: 0.006
-
Physician-patient interactions and outcomes in systemic lupus erythematosus (SLE): a conceptual model. Lupus. 2013 Sep; 22(10):1038-45.
Score: 0.006
-
Effect of belimumab on vaccine antigen antibodies to influenza, pneumococcal, and tetanus vaccines in patients with systemic lupus erythematosus in the BLISS-76 trial. J Rheumatol. 2012 Aug; 39(8):1632-40.
Score: 0.006
-
Disease-specific patient reported outcome tools for systemic lupus erythematosus. Semin Arthritis Rheum. 2012 Aug; 42(1):56-65.
Score: 0.005
-
Osteopontin alleles are associated with clinical characteristics in systemic lupus erythematosus. J Biomed Biotechnol. 2011; 2011:802581.
Score: 0.005
-
Predicting outcomes of lupus nephritis with tubulointerstitial inflammation and scarring. Arthritis Care Res (Hoboken). 2011 Jun; 63(6):865-74.
Score: 0.005
-
Network analysis of associations between serum interferon-a activity, autoantibodies, and clinical features in systemic lupus erythematosus. Arthritis Rheum. 2011 Apr; 63(4):1044-53.
Score: 0.005
-
In situ B cell-mediated immune responses and tubulointerstitial inflammation in human lupus nephritis. J Immunol. 2011 Feb 01; 186(3):1849-60.
Score: 0.005
-
The lupus family registry and repository. Rheumatology (Oxford). 2011 Jan; 50(1):47-59.
Score: 0.005
-
Efficacy and safety of rituximab in moderately-to-severely active systemic lupus erythematosus: the randomized, double-blind, phase II/III systemic lupus erythematosus evaluation of rituximab trial. Arthritis Rheum. 2010 Jan; 62(1):222-33.
Score: 0.005
-
Age- and gender-specific modulation of serum osteopontin and interferon-alpha by osteopontin genotype in systemic lupus erythematosus. Genes Immun. 2009 Jul; 10(5):487-94.
Score: 0.004